Ileal smooth muscle dysfunction and remodeling in cystic fibrosis

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 303, Issue 1, 2012, Pages

  Risse, P A ^a   Kachmar, L ^a   Matusovsky, O S ^a   Novali, M ^a   Gil, F R ^a   Javeshghani, S ^a   Keary, R ^a   Haston, C K ^a   Michoud, M C ^a   Martin, J G ^a   Lauzon, A M ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Cystic fibrosis transmembrane conductance regulator; Force velocity; Hyperresponsivness; Hypertrophy; Isometric force

Indexed keywords

ISOPRENALINE; MYOSIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DENSITY; CYSTIC FIBROSIS; ELECTRIC FIELD; ELECTROSTIMULATION; ILEUM; IN VIVO STUDY; MOUSE; MUSCLE CONTRACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE; SMOOTH MUSCLE RELAXATION;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; ANIMALS; BLOTTING, WESTERN; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ELECTRIC STIMULATION; ILEUM; ISOPROTERENOL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCARINIC AGONISTS; MUSCLE CONTRACTION; MUSCLE TONUS; MUSCLE, SMOOTH; MYOSIN HEAVY CHAINS;

EID: 84863533757     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00356.2011     Document Type: Article

References (34)

1. Akiho H, Deng Y, Blennerhassett P, Kanbayashi H, Collins SM. Mechanisms underlying the maintenance of muscle hypercontractility in a model of postinfective gut dysfunction. Gastroenterology 129: 131-141, 2005.
2. Avital A, Sanchez I, Chernick V. Efficacy of salbutamol and ipratropium bromide in decreasing bronchial hyperreactivity in children with cystic fibrosis. Pediatr Pulmonol 13: 34-37, 1992.
3. Bentur L, Hino B, Shamir R, Elias N, Hartman C, Eshach-Adiv O, Berkowitz D. Impaired gastric myolectrical activity in patients with cystic fibrosis. J Cyst Fibros 5: 187-191, 2006.
4. Canale-Zambrano JC, Haston CK. IGF binding protein-3 treatment alters intestinal cell proliferation but not body weight of adult cystic fibrosis transmembrane conductance regulator deficient mice. Pediatr Res 69: 129-134, 2011.
5. Cohen JC, Larson JE. Cystic fibrosis transmembrane conductance regulator (CFTR) dependent cytoskeletal tension during lung organogenesis. Dev Dyn 235: 2736-2748, 2006.
6. Constantine S, Au VW, Slavotinek JP. Abdominal manifestations of cystic fibrosis in adults: a review. Australas Radiol 48: 450-458, 2004.
7. Davis PB. Autonomic and airway reactivity in obligate heterozygotes for cystic fibrosis. Am Rev Respir Dis 129: 911-914, 1984.
8. Davis PB, Byard PJ. Relationships among airway reactivity, pupillary alpha-adrenergic and cholinergic responsiveness, and age. J Appl Physiol 65: 200-204, 1988.
9. De Lisle RC, Meldi L, Roach E, Flynn M, Sewell R. Mast cells and gastrointestinal dysmotility in the cystic fibrosis mouse. PLos One 4: e4283, 2009.
10. de Lisle RC, Sewell R, Meldi L. Enteric circular muscle dysfunction in the cystic fibrosis mouse small intestine. Neurogastroenterol Motil 22: 341-387, 2010.
11. Govindaraju V, Michoud MC, Ferraro P, Arkinson J, Safka K, Valderrama-Carvajal H, Martin JG. The effects of interleukin-8 on airway smooth muscle contraction in cystic fibrosis. Respir Res 9: 76, 2008.
12. Haston CK, Cory S, Lafontaine L, Dorion G, Hallett MT. Straindependent pulmonary gene expression profiles of a cystic fibrosis mouse model. Physiol Genomics 25: 336-345, 2006.
13. Haston CK, Li W, Li A, Lafleur M, Henderson JE. Persistent osteopenia in adult cystic fibrosis transmembrane conductance regulator-deficient mice. Am J Respir Crit Care Med 177: 309-315, 2008.
14. Hays SR, Ferrando RE, Carter R, Wong HH, Woodruff PG. Structural changes to airway smooth muscle in cystic fibrosis. Thorax 60: 226-228, 2005.
15. Hill AV. The heat of activation and the heat of shortening in a muscle twitch. Proc R Soc Lond B Biol Sci 136: 195-211, 1949.
16. Jackson R, Pencharz PB. Transition of care between paediatric and adult gastroenterology. Cystic fibrosis. Best Pract Res Clin Gastroenterol 17: 213-235, 2003.
17. Khoshoo V, Udall JN Jr. Meconium ileus equivalent in children and adults. Am J Gastroenterol 89: 153-157, 1994.
18. Lauzon AM, Tyska MJ, Rovner AS, Freyzon Y, Warshaw DM, Trybus KM. A 7-amino-acid insert in the heavy chain nucleotide binding loop alters the kinetics of smooth muscle myosin in the laser trap. J Muscle Res Cell Motil 19: 825-837, 1998.
19. Meyerholz DK, Stoltz DA, Pezzulo AA, Welsh MJ. Pathology of gastrointestinal organs in a porcine model of cystic fibrosis. Am J Pathol 176: 1377-1389, 2010.
20. Michoud MC, Robert R, Hassan M, Moynihan B, Haston C, Govindaraju V, Ferraro P, Hanrahan JW, Martin JG. Role of the cystic fibrosis transmembrane conductance channel in human airway smooth muscle. Am J Respir Cell Mol Biol 40: 217-222, 2009.
21. Minkes RK, Langer JC, Skinner MA, Foglia RP, O'Hagan A, Cohen AH, Mallory GB, Huddleston CB, Mendeloff EN. Intestinal obstruction after lung transplantation in children with cystic fibrosis. J Pediatr Surg 34: 1489-1493, 1999.
22. Norkina O, Kaur S, Ziemer D, De Lisle RC. Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 286: G1032-G1041, 2004.
23. Regamey N, Ochs M, Hilliard TN, Muhlfeld C, Cornish N, Fleming L, Saglani S, Alton EW, Bush A, Jeffery PK, Davies JC. Increased airway smooth muscle mass in children with asthma, cystic fibrosis, and noncystic fibrosis bronchiectasis. Am J Respir Crit Care Med 177: 837-843, 2008.
24. Robert R, Savineau JP, Norez C, Becq F, Guibert C. Expression and function of cystic fibrosis transmembrane conductance regulator in rat intrapulmonary arteries. Eur Respir J 30: 857-864, 2007.
25. Robert R, Thoreau V, Norez C, Cantereau A, Kitzis A, Mettey Y, Rogier C, Becq F. Regulation of the cystic fibrosis transmembrane conductance regulator channel by beta-adrenergic agonists and vasoactive intestinal peptide in rat smooth muscle cells and its role in vasorelaxation. J Biol Chem 279: 21160-21168, 2004.
26. Robertson MB, Choe KA, Joseph PM. Review of the abdominal manifestations of cystic fibrosis in the adult patient. Radiographics 26: 679-690, 2006.
27. Rogers CS, Stoltz DA, Meyerholz DK, Ostedgaard LS, Rokhlina T, Taft PJ, Rogan MP, Pezzulo AA, Karp PH, Itani OA, Kabel AC, Wohlford-Lenane CL, Davis GJ, Hanfland RA, Smith TL, Samuel M, Wax D, Murphy CN, Rieke A, Whitworth K, Uc A, Starner TD, Brogden KA, Shilyansky J, McCray PB Jr, Zabner J, Prather RS, Welsh MJ. Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs. Science 321: 1837-1841, 2008.
28. Sa-Nunes A, Corrado AP, Baruffi MD, Faccioli LH. Disodium cromoglycate prevents ileum hyperreactivity to histamine in Toxocara canis-infected guinea pigs. Pharmacol Res 48: 451-455, 2003.
29. Sanchez I, Powell RE, Pasterkamp H. Wheezing and air-flow obstruction during methacholine challenge in children with cystic-fibrosis and in normal-children. Am Rev Respir Dis 147: 705-709, 1993.
30. Tamaoka M, Hassan M, McGovern T, Ramos-Barbon D, Jo T, Yoshizawa Y, Tolloczko B, Hamid Q, Martin JG. The epidermal growth factor receptor mediates allergic airway remodelling in the rat. Eur Respir J 32: 1213-1223, 2008.
31. Vandebrouck C, Melin P, Norez C, Robert R, Guibert C, Mettey Y, Becq F. Evidence that CFTR is expressed in rat tracheal smooth muscle cells and contributes to bronchodilation. Respir Res 7: 113, 2006.
32. Vanharen EHJ, Lammers JWJ, Festen J, Vanherwaarden CLA. Bronchial vagal tone and responsiveness to histamine, exercise and bronchodilators in adult patients with cystic-fibrosis. Eur Respir J 5: 1083-1088, 1992.
33. White S, Martin AF, Periasamy M. Identification of a novel smooth muscle myosin heavy chain cDNA: isoform diversity in the S1 head region. Am J Physiol Cell Physiol 264: C1252-C1258, 1993.
34. Yamada T. Textbook of Gastroenterology. Hoboken, NJ: Wiley-Blackwell, 2009.